BIOMARKERS OF AGING - DO WE KNOW WHAT TO LOOK FOR

被引：30
|
作者：
MOORADIAN, AD
机构：
来源：
JOURNALS OF GERONTOLOGY | 1990年 / 45卷 / 06期
关键词：
D O I：
10.1093/geronj/45.6.B183
中图分类号：
R4 [临床医学]; R592 [老年病学];
学科分类号：
1002 ; 100203 ; 100602 ;
摘要：
The identification of specific biomarkers of aging would be an important milestone in gerontologic research. In this communication, the goals of identifying biomarkers of aging are summarized and some criteria for defining biomarkers are suggested. An age-related alteration in a biological parameter is not necessarily a biomarker of aging. None of the previously observed age-related changes satisfies all the criteria. Potential biomarkers that are applicable to human aging include in vitro proliferative capacity of fibroblasts, glycation of collagen, and DNA unwinding rate. Future research should focus on identifying age-related changes that are not merely expressions of aging, but also have some causal link to aging.
引用
下载
收藏
页码：B183 / B186
页数：4
相关论文
共 50 条
  • [41] ECONOMIC NETWORKS: WHAT DO WE KNOW AND WHAT DO WE NEED TO KNOW?
    Schweitzer, Frank
    Fagiolo, Giorgio
    Sornette, Didier
    Vega-Redondo, Fernando
    White, Douglas R.
    ADVANCES IN COMPLEX SYSTEMS, 2009, 12 (4-5): : 407 - 422
  • [42] Dietary interventions for AMD: what do we know and what do we not know?
    Evans, Jennifer R.
    Lawrenson, John G.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (09) : 1089 - 1090
  • [43] Pediatric stroke: What do we know and what do we need to know?
    Lynch, JK
    Han, CJ
    SEMINARS IN NEUROLOGY, 2005, 25 (04) : 410 - 423
  • [44] DO WE KNOW WHAT WE DONT KNOW
    LITTLE, B
    JOURNAL OF PRODUCT INNOVATION MANAGEMENT, 1985, 2 (01) : 1 - 2
  • [45] What do we know about biomarkers in diabetic kidney disease?
    Kwiendacz, Hanna
    Nabrdalik, Katarzyna
    Stompor, Tomasz
    Gumprecht, Janusz
    ENDOKRYNOLOGIA POLSKA, 2020, 71 (06) : 545 - 550
  • [46] How do we know what we know?
    Hug, Joa
    FILOSOFICKY CASOPIS, 2015, 63 (01): : 150 - 153
  • [47] HOW DO WE KNOW WHAT WE KNOW?
    Manton, Anne
    JOURNAL OF EMERGENCY NURSING, 2015, 41 (05) : 372 - 372
  • [48] Acetaminophen hepatoxicity: What do we know, what don't we know, and what do we do next?
    Kaplowitz, N
    HEPATOLOGY, 2004, 40 (01) : 23 - 26
  • [49] How do we know what we know?
    Dhara, Arundhati
    CANADIAN FAMILY PHYSICIAN, 2021, 67 (11) : 851 - 852
  • [50] WHAT DO WE KNOW - WHAT SHALL WE DO - WHAT DO WE TELL
    Radstake, Timothy R.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 48 - 49
12345